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PRisk of Ventricular Arrhythmia After Implantable
Defibrillator Treatment in Anxious Type D Patients
Krista C. van den Broek, PHD,* Ivan Nyklı´cˇek, PHD,* Pepijn H. van der Voort, MD,†
Marco Alings, MD, PHD,‡ Albert Meijer, MD, PHD,† Johan Denollet, PHD*
Tilburg, Eindhoven, and Breda, the Netherlands
Objectives We sought to examine the combination of adverse psychological factors (anxiety, depression, and distressed or
Type D personality) as a predictor of ventricular arrhythmias in patients with implantable cardioverter-
defibrillators (ICDs).
Background Little is known about the role of psychological factors and their clustering in the occurrence of life-threatening
arrhythmias.
Methods In this prospective study, 391 patients with an ICD (81% men, age 62.3  10.4 years) completed anxiety, de-
pression, and Type D personality scales at the time of implantation. The end point was occurrence of ventricular
arrhythmia, defined as appropriate ICD therapies, in the first year after implantation.
Results Ventricular arrhythmias occurred in 19% (n  75) of patients. Increased symptoms of depression (p  0.81) or
anxiety (p  0.31) did not predict arrhythmias. However, anxious patients with a Type D personality had a signifi-
cantly increased rate of ventricular arrhythmias (21 of 71; 29.6%) as compared with other ICD patients (54 of
320; 16.9%; hazard ratio [HR]: 1.89; 95% confidence interval [CI]: 1.14 to 3.13; p  0.013). When controlled for
the effects of sex, age, ischemic etiology, left ventricular dysfunction, prolonged QRS duration, and medication,
anxious Type D patients (HR: 1.72; 95% CI: 1.03 to 2.89; p  0.039) and secondary prevention patients (HR:
1.91; 95% CI: 1.14 to 3.20; p  0.014) were at increased risk of ventricular arrhythmias.
Conclusions Personality modulated the effect of emotional distress; anxiety predicted a 70% increase in risk of arrhythmia in
Type D patients but not in other patients. Anxious Type D patients may be identified and offered additional be-
havioral support after ICD implantation. (J Am Coll Cardiol 2009;54:531–7) © 2009 by the American College
of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.04.043s
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pmplantable cardioverter-defibrillator (ICD) treatment pro-
ides an opportunity to study factors associated with ven-
ricular arrhythmia as the most common cause of sudden
ardiac death (1). Guidelines (2,3) advocate ICD implan-
ation in patients who have survived life-threatening ar-
hythmias and in patients with severe left ventricular dys-
unction. The use of an ICD does not prevent ventricular
rrhythmias, but the ICD can terminate ventricular arrhyth-
ias by antitachycardia pacing (ATP) or high-voltage
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009, accepted April 26, 2009.hocks (4). However, patient selection for ICD implanta-
ion remains an important clinical issue, and better knowl-
dge of risk factors for ventricular arrhythmias is needed
1,5). Moreover, sudden cardiac death caused by ventricular
rrhythmias may still occur in a small proportion of ICD
atients (6), which points out the importance of studying
riggers and risk factors of ventricular arrhythmias after ICD
reatment.
Clinical risk factors for ventricular arrhythmia include
schemic heart disease (1), New York Heart Association
unctional class III (7) or IV (8), previous ventricular
rrhythmias (8), low left ventricular ejection fraction, QRS
uration, and atrial fibrillation (9), but an unresolved issue is
he role of emotional distress (10). Some studies found that
hocked patients experience anxiety (11–14), depression
15), and impaired quality of life (16), although others
17–19) did not find this association. However, only a few
tudies have evaluated the role of emotional distress as
recipitant of ventricular arrhythmias in patients with an
CD (20–23), with 2 studies (21,22) investigating emo-
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arrhythmias, and 1 study (23)
investigating acute emotional
triggers.
Depression has been associated
with ventricular arrhythmias (20),
whereas others found that anxiety,
but not depression and anger
(21), or anger, but not sadness
and anxiety (23), may trigger
ventricular arrhythmias. These
mixed findings indicate that
other factors may modulate the
effect of emotional distress, and
evidence suggests that stable per-
sonality traits may increase the
risk of emotion-triggered appro-
riate shocks in ICD patients (23). Of note, psychological
isk factors do not occur in isolation (24) but rather tend to
luster together within cardiac patients to increase the risk
f clinical events (25).
Therefore, the objective of this prospective study was to
xamine the extent to which Type D personality (i.e., the
endency to experience emotional and social distress) may
odulate the association between anxiety/depression and
entricular arrhythmia. Previously, we have argued that
esearch should focus on the interaction of psychological
actors (24,26), and we have shown that clustering of Type
personality with other psychological factors increases the
isk of adverse outcomes (12,27). In the present study, we
xamined the role of anxiety, depression, and their combi-
ation with Type D personality as predictors of ventricular
rrhythmias during the 12-month period after ICD implan-
ation, adjusting for sex, age, ICD indication, etiology,
jection fraction, QRS duration, and medical treatment.
ethods
atient sample. Patients who underwent ICD implanta-
ion between May 2003 and December 2006 were included
rom 2 referral hospitals in the Netherlands (Catharina
ospital, Eindhoven; Amphia Hospital, Breda). Inclusion
riteria were implantation with an ICD and age between 18
nd 80 years. Exclusion criteria were significant cognitive
mpairments (e.g., dementia), life-threatening comorbidi-
ies (e.g., cancer), and insufficient knowledge of the Dutch
anguage. Patients who died during the 12-month
ollow-up period were not excluded from the analyses
ecause these patients could also have experienced ventric-
lar arrhythmias during their follow-up period. The study
as approved by the Medical Ethics Committees of both
articipating hospitals. The study was conducted in accor-
ance with the Helsinki Declaration, and all patients
rovided written informed consent.
sychological measures. Patients completed question-
Abbreviations
and Acronyms
ACE  angiotensin-
converting enzyme
ATP  antitachycardia
pacing
BDI  Beck Depression
Inventory
CI  confidence interval
DS14  Type D scale
HR  hazard ratio
ICD  implantable
cardioverter-defibrillator
STAI  State Trait Anxiety
Inventoryaires on depressive symptoms, anxiety, and personality in dhe period between 1 day before ICD implantation and 3
eeks after ICD implantation.
EPRESSIVE SYMPTOMS. The Beck Depression Inventory
BDI) is a 21-item self-report measure developed to assess
he presence and severity of depressive symptoms (28). Each
tem is rated on a Guttmann scale from 0 to 3. The BDI is
reliable and valid measure of depressive symptomatology
nd the most frequently used self-report measure of depres-
ive symptoms in cardiac patients. Scores 10 were used to
ndicate clinically relevant levels of depression (28,29).
NXIETY. The State Trait Anxiety Inventory (STAI) was
sed to assess general symptoms of anxiety (30). In the
urrent study, we only used the state measure because the
urpose of this study was to assess the current presence of
ymptoms of anxiety at baseline. The STAI state version
onsists of 20 items and each item is rated on a 4-point
ikert scale from 1 (not at all) to 4 (very much so), with total
cores ranging from 20 to 80, with higher scores indicating
reater levels of state-anxiety. The STAI has adequate
alidity and reliability, with Cronbach’s alpha ranging from
.87 to 0.92 (30). To indicate clinically elevated levels of
eneral anxiety, a cut-off of 40 was used, which was
reviously used in studies on ICD (31).
YPE D PERSONALITY. The Type D scale (DS14) was used to
ssess Type D personality. Type D patients tend to experi-
nce increased negative emotions (e.g., worry and have a
loomy view of life) paired with emotional nonexpression
32). The DS14 contains 2 scales of 7 items each: Negative
ffectivity (e.g., “I often feel unhappy”) and Social Inhibi-
ion (e.g., “I am a closed kind of person”) (32). Items are
nswered on a 5-point Likert scale, ranging from 0 (false) to
(true), with total scores ranging from 0 to 28 for both
ubscales. Patients scoring 10 on both subscales are
lassified as Type D (32,33). The DS14 has good reliability,
ith a Cronbach’s alpha of 0.88 and 0.86 and 3-month
est-retest reliability of 0.72 and 0.82 for Negative Affec-
ivity and Social Inhibition, respectively (32). The DS14 is
stable personality measure during an 18-month period
fter an acute event (34), and scores are not confounded by
ardiac disease severity or symptoms of anxiety and depres-
ion (34,35). Previous studies have shown an association
etween Type D personality and adverse clinical outcome,
ncluding mortality and morbidity (36–40).
emographic and clinical variables. Demographic vari-
bles included sex and age. Clinical variables included ICD
ndication (primary vs. secondary prevention), etiology
ischemic vs. nonischemic), severely decreased ejection frac-
ion (left ventricular ejection fraction 35% vs. 35%),
rolonged QRS duration (QRS duration120 ms vs.120
s), and prescription of angiotensin-converting enzyme
ACE) inhibitors or beta-blockers. These variables were
btained from medical records at baseline.
entricular arrhythmias. Ventricular arrhythmias were
efined by appropriate ICD therapies, either ATPs or
s
v
t
t
a
c
h
i
r
d
t
1
s
p
A
c
a
e
t
S
a
a
i
c
d
o
t
p
T
u
d
c
f
a
f
t
m
N
m
d
d
p
s
o
(
i
u
a
s
a
(
i
R
P
p
i
d
(
p
d
i
s
m
d
a
a
p
a
V
p
r
(
a
o
o
t
P
U
p
o
d
B
*
533JACC Vol. 54, No. 6, 2009 van den Broek et al.
August 4, 2009:531–7 Anxiety, Personality, and Ventricular Arrhythmiahocks, which were delivered for ventricular tachycardia or
entricular fibrillation. Patients visited the center of implan-
ation at regular intervals (mostly 3 or 6 months). During
hese visits arrhythmic events were recorded from the ICD
nd stored. Only a small number of patients did not visit the
enter of implantation but instead went to their own
ospital. Therefore, these hospitals were contacted for
nformation on arrhythmic events. None of the patients had
emote monitoring systems. Because the study extended
uring a 12-month period, beginning with ICD implanta-
ion, we specifically included patients who already had their
2-month check-up in the hospital. Only the most aggres-
ive treatment per episode was counted, meaning that if a
atient experienced a ventricular arrhythmia for which first
TPs were delivered and then shocks, this episode was only
ounted as one shock. The occurrence of appropriate ATPs
nd shocks were obtained from medical records, with
lectrophysiologists judging the appropriateness of ICD
herapies on the basis of electrocardiograms.
tatistical analyses. Differences between groups were ex-
mined with a chi-square test (likelihood ratio where
ppropriate) for dichotomous variables and a t test for
ndependent samples for continuous variables. To enhance
linical interpretability, anxiety and depression scores were
ichotomized. As has been advocated previously, research
n adverse outcomes should not only focus on the prognos-
ic value of isolated psychological factors but also on the
rognostic value of the interaction of these factors (24,25).
his approach was adopted in our analyses. A series of
nivariable Cox regression analyses were performed to
etermine whether increased depressive symptoms, in-
reased anxiety, Type D personality, and clustering of these
actors predicted ventricular arrhythmias in the first year
fter ICD implantation. If a clustering of psychological
actors was significant, the independent value of this clus-
ering was tested first in a multivariable Cox analysis (enter
ethod) that also included the main effects of these factors.
ext, a multivariable Cox regression analysis (enter
ethod) was performed, including the psychological pre-
ictor(s), and age, sex, ICD indication, etiology, severely
ecreased ejection fraction, prolonged QRS duration, and
rescription of ACE inhibitors or beta-blockers.
aseline Demographic and Clinical Characteristics of 391 PatientsTable 1 Baseline Demographic and Clinical Characteristics of 3
Characteristics % (n
Males 80.6 (3
Age (yrs), mean  SD 62.3 
Secondary prevention 42.7 (1
Nonischemic etiology 28.6 (1
Severely decreased ejection fraction† 81.8 (3
Prolonged QRS duration‡ 58.8 (2
No prescription of angiotensin-converting enzyme inhibitor 32.0 (1
No prescription of beta-blocker 16.9 (6p  0.10 are presented in bold. †Ejection fraction 35%. ‡QRS duration 120 ms.Because multicollinearity may affect parameters in regres-
ion analyses, we performed a linear regression analysis to
btain tolerance and variance inflation factor (VIF) values
41), with a tolerance value 0.10 or a VIF value 10
ndicating multicollinearity. The Kaplan-Meier method was
sed to graphically present the time to first ventricular
rrhythmia, and the log-rank test was performed to test for
ignificant differences between the groups. All data were
nalyzed with the use of SPSS version 16.0 for Windows
SPSS Inc., Chicago, Illinois), and p  0.05 was used to
ndicate statistical significance.
esults
atient characteristics. Of the 432 patients who agreed to
articipate in the study, 391 (90.5%) patients were included
n the analyses. Patients who were not included had missing
ata on self-report measures (n  10) or clinical variables
n  31). Included patients did not differ from excluded
atients on any of the baseline characteristics. Table 1 shows
emographic and clinical characteristics of the 391 patients
ncluded in the study, both for the total sample and
tratified by occurrence of appropriate ICD therapies. The
ean anxiety score (STAI) was 39.5  11.7, and the mean
epressive score (BDI) was 8.9  6.7. Increased levels of
nxiety were experienced by 47.8% (187 of 391) of patients
nd increased levels of depression by 35.3% (138 of 91) of
atients. Finally, 23% (90 of 391) of patients were classified
s a Type D.
entricular arrhythmias. During the first year after im-
lantation, 75 patients (19.2%) experienced ventricular ar-
hythmias with appropriate therapies, and 21 patients
4.6%) died. Of the 75 patients, 52.1% of patients only had
ppropriate ATP-only episode(s), 23.3% only had shock-
nly episodes, and 24.7% had both ATP-only and shock-
nly episodes. The median number of appropriate ICD
herapies was 2, with a range from 1 to 1,100 episodes.
sychological predictors of ventricular arrhythmias.
nivariable Cox regression analyses showed that secondary
revention (p  0.004) was a significant predictor of
ccurrence of ventricular arrhythmia, but none of the other
emographic or clinical variables were related to ventricular
ded in the Analysesatients Included in the Analyses
Appropriate Therapy for Ventricular Arrhythmia
No, % Yes, % p Value*
81.0 78.7 0.64
62.7 10.5 60.5  9.8 0.097
39.2 57.3 0.004
27.8 32.0 0.48
82.9 77.3 0.26
59.8 54.7 0.42
31.6 33.3 0.78
15.2 24.0 0.067Inclu91 P
)
15)
10.4
67)
12)
20)
30)
25)
6)
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Anxiety, Personality, and Ventricular Arrhythmia August 4, 2009:531–7rrhythmia (Table 2). Regarding isolated psychological factors;
ncreased anxiety (p 0.31) and depression (p 0.81) did not
redict arrhythmias, but there was a trend for Type D
ersonality (p  0.079), with 29.6% (21 of 71) of Type D
atients and 16.9% (54 of 320) of non-Type D patients having
xperienced ventricular arrhythmias.
Finally, Table 2 shows prognostic values of clustering of
sychological factors. Clustering of anxiety and depres-
ion (p  0.91) and depression and Type D personality
p  0.18) did not significantly relate to arrhythmia. How-
ver, the combined presence of anxiety and Type D personality
id significantly predict ventricular arrhythmias (p  0.013).
ndependent predictors of ventricular arrhythmias. After
ontrolling for anxiety and personality main effects, the
nxiety  Type D interaction effect still was significant
hazard ratio [HR]: 2.09; 95% confidence interval [CI]:
.01 to 4.39; p 0.049), whereas the anxiety (p 0.74) and
ype D (p  0.56) main effects were not. Hence, anxiety
nly had an impact when Type D personality was present.
tratification of patients in 4 distinct anxiety/Type D
ubgroups confirmed that anxious Type D patients (HR:
.77; 95% CI: 1.02 to 3.06; p  0.041) but not anxious
on-Type D (p  0.71) or nonanxious Type D (p  0.43)
atients had an increased risk of ventricular arrhythmia
ompared with the reference group (low anxiety and non-
ype D). Because it was the clustering of anxiety and Type
that was associated with an increased arrhythmia risk, this
ombination was further examined in a multivariable model
ncluding demographic and clinical characteristics.
The tests for multicollinearity were negative, with all
olerance values ranging from 0.65 to 0.97 and VIF values
rom 1.03 to 1.54, which demonstrates the absence of
nivariable Predictors of Ventricular ArrhythmiasTable 2 Univariable Predictors of Ventricular Arrhythmias
Variables
Ventricular Arrhythmias
HR 95% CI p Value*
Demographic and clinical factors
Male 0.91 0.521.58 0.74
Age 0.98 0.961.00 0.087
Secondary prevention 1.96 1.243.10 0.004
Nonischemic etiology 1.18 0.731.92 0.50
Severely decreased ejection fraction† 0.74 0.431.27 0.27
Prolonged QRS duration‡ 0.81 0.521.28 0.37
No prescription of angiotensin-converting
enzyme inhibitor
1.07 0.671.74 0.77
No prescription of beta-blocker 1.68 0.992.85 0.056
Isolated psychological factors
Increased depressive symptoms 1.06 0.661.70 0.81
Increased anxiety 1.26 0.801.99 0.31
Type D personality 1.55 0.952.54 0.079
Clustering of psychological factors
Depression  anxiety 1.03 0.621.72 0.91
Depression  Type D personality 1.49 0.832.66 0.18
Anxiety  Type D personality 1.89 1.143.13 0.013t
p  0.10 are presented in bold. †Ejection fraction 35%. ‡QRS duration 120 ms.
CI  confidence interval; HR  hazard ratio.ulticollinearity. Hence, these variables did not have sig-
ificant overlap, and they could be entered in the model at
he same time.
In the multivariable Cox regression analysis (enter model),
djusting for sex, age, secondary prevention, nonischemic
tiology, severely decreased ejection fraction, prolonged QRS
uration, and prescription of ACE inhibitors or beta-blockers,
lustering of anxiety and Type D personality remained signif-
cant with a 1.7-fold risk. In addition, secondary prevention
as associated with a 1.9-fold risk to experience ventricular
rrhythmias (Table 3).
entricular arrhythmias in anxious Type D patients.
aplan-Meier curves for the time to first ventricular arrhyth-
ia for anxious Type D patients versus the other patients are
hown in Figure 1. The log-rank test was significant (chi-
quare  6.33, degrees of freedom  1, p  0.012), with
nxious Type D patients experiencing earlier and more often
entricular arrhythmia as compared with other ICD patients.
iscussion
n this prospective study, we examined the extent to which
ype D personality may modulate the association between
nxiety/depression and ventricular arrhythmia in the first
ear after ICD implantation. Clustering of increased anxiety
t the time of implantation and having a Type D personality
redicted arrhythmia, with its 1.7-fold independent risk
eing comparable with the 1.9-fold risk for secondary
revention patients.
Previous studies on psychological risk factors or triggers
f ventricular arrhythmia in ICD patients yielded mixed
ndings, but none of these studies focused on a clustering of
sychological risk factors. The findings of the present study
upport the notion that psychological factors may cluster in
CD patients which, in turn, increases the risk for adverse
utcomes (24,26,27,42–46). More specifically, the finding
hat clustering of anxiety and Type D personality was a risk
actor for adverse outcomes has also been described previ-
usly, including in ICD patients (12,27). Hence, the fact
ultivariable Predictors of Ventricular ArrhythmiasTable 3 Multivariable Predictors of Ventricular Arrhythmias
Ventricular Arrhythmias
HR 95% CI p Value*
Male 1.02 0.561.86 0.94
Age 0.98 0.961.01 0.16
Secondary prevention 1.91 1.143.20 0.014
Nonischemic etiology 1.08 0.611.92 0.80
Severely decreased ejection fraction† 1.30 0.632.67 0.47
Prolonged QRS duration‡ 0.98 0.591.61 0.92
No prescription of angiotensin-converting
enzyme inhibitor
1.05 0.621.76 0.86
No prescription of beta-blocker 1.54 0.892.66 0.12
Anxious Type D cluster 1.72 1.032.89 0.039
p  0.10 are presented in bold. †Ejection fraction 35%. ‡QRS duration 120 ms.
Abbreviations as in Table 2.hat the combined presence of negative emotional states and
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August 4, 2009:531–7 Anxiety, Personality, and Ventricular Arrhythmiaype D personality incurs the highest adverse risk should be
aken into account in future studies.
Results of the current study suggest that the relationship
etween psychological distress and morbidity and mortality
36–39,47) may be mediated by occurrence of ventricular
rrhythmias. However, pathways or mechanisms linking
motions and personality traits in general and anxiety and
ype D personality in particular to arrhythmias are not well
nown and should be explored further in future research.
tress may be associated with increased sympathetic tone
nd its detrimental effects on arrhythmia (48,49). Experi-
ental studies have shown that general mental stress may
nduce increased T-wave alternans (50), which is associated
ith ventricular arrhythmias and death (51). Mental stress
ay also shorten the cycle length of ventricular tachycardia
nd consequently result in more difficult termination of this
rrhythmia (52).
Secondary prevention was also significantly predictive for
entricular arrhythmias, whereas sex, age, nonischemic eti-
logy, severely decreased ejection fraction, prolonged QRS
uration, and prescription of ACE inhibitors or beta-
lockers were not. The findings on indication, sex, and age
re in line with results from previous research (8,21,53,54),
lthough older and male patients may be at increased risk
or ventricular arrhythmias (55). Because ischemic etiology,
Figure 1
Kaplan-Meier Curve for Time to
First Ventricular Arrhythmia in Type D
Patients With Increased Anxiety (p  0.012)
Other groups (blue line); anxious Type D patients (green line).everely decreased ejection fraction, and prolonged QRS
Nuration have been identified as precipitants of ventricular
rrhythmias (1,9) whereas ACE inhibitors and beta-
lockers have been found to have antiarrhythmic effects
56), it is difficult to explain the nonsignificant findings.
Screening for anxiety and Type D personality may be
tandardized in clinical practice because both factors have
een associated with adverse outcomes in ICD patients
14,17,19,57,58). A recent review indicates that cognitive-
ehavioral therapy paired with exercise training may be
ost useful to diminish anxiety symptoms in ICD patients
59). Interventions for Type D personality may aim at
hanging coping styles for dealing with negative emotions.
ecause only a few studies have focused on psychological
ntervention in ICD patients (59) and because no study has
nvestigated interventions for Type D patients, more re-
earch is needed on this topic, particularly regarding the role
f supportive or medical therapy with respect to occurrence
f ventricular arrhythmias in Type D patients.
tudy limitations. First, ventricular arrhythmias without
herapy were not included. Second, because the cause of
eath is not known for most of the patients, it is unknown,
lthough unlikely, whether death was attributable to ven-
ricular arrhythmia. Third, anxiety was only measured at the
ime of implantation, which provided no information about
he course of anxiety levels. However, a previous publication
ased on this sample suggested that baseline levels of anxiety
id not differ from levels at 2 months after implantation
13). In addition, other studies suggest stability of anxiety
evels (11,18).
onclusions
his prospective study suggests that patients with both
nxiety and a Type D personality, and patients with a
econdary prevention are at increased risk to experience
entricular arrhythmias in the first year after ICD implan-
ation. In clinical practice, anxious Type D patients should
e identified and offered adequate support. Future studies
ay focus on the prevalence and prognostic value of
lustering of psychological risk factors, but also on the role
f supportive therapy in these patients. In addition, mech-
nisms and pathways linking anxiety and personality traits
o ventricular arrhythmias need to be studied.
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